home / stock / nvcn:cc / nvcn:cc news

NVCN:CC News and Press, Neovasc Inc.

Stock Information
Company Name: Neovasc Inc.
Stock Symbol: NVCN:CC
Market: TSXC
Website: neovasc.com
Menu
NVCN:CC NVCN:CC Quote NVCN:CC Short NVCN:CC News NVCN:CC Articles NVCN:CC Message Board
Get NVCN:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
NVCN:CC - Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update

VANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the fourth quarter and year ended December 31, 2022. Recent Hi...
NVCN:CC - Neovasc Shareholders Approve Acquisition by Shockwave Medical

VANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, is pleased to announce that its Shareholders (as d...

NVCN:CC - Neovasc Announces German Reimbursement Renewal

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 1, 2023) - Neovasc, Inc. (NASDAQ : NVCN) (TSX : NVCN) ("Neovasc" or "the Company") today announced the German Institute for the Hospital Remuneration System ("InEK") has awarded the Neovasc Reducer™ ("Redu...

NVCN:CC - IIROC Trade Resumption - NVCN

IIROC Trade Resumption - NVCN Canada NewsWire TORONTO , Jan. 17, 2023 /CNW/ - Trading resumes in: Company: Neovasc Inc. TSX Symbol: NVCN All Issues: Yes Resumption (ET): 8:30 AM IIROC can make a decision to impose a temporary suspension (halt)...
NVCN:CC - IIROC Trading Halt - NVCN

IIROC Trading Halt - NVCN Canada NewsWire TORONTO , Jan. 17, 2023 /CNW/ - The following issues have been halted by IIROC: Company: Neovasc Inc. TSX Symbol: NVCN All Issues: Yes Reason: Pending News Halt Time (ET): 8‎:00‎ &#...

NVCN:CC - Shockwave Medical Announces Agreement to Acquire Neovasc

Neovasc’s Innovative Reducer System Will Target the Estimated $5 Billion Refractory Angina Market Shockwave Medical Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Full Year 2023 Revenue Guidance SANTA CLARA, Calif., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Sh...

NVCN:CC - Shockwave Medical to Acquire Neovasc

VANCOUVER, BC, Jan. 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (" Neovasc " or the " Company ") (NASDAQ,TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, announced today that the Company has entere...
NVCN:CC - Neovasc Announces Progress on COSIRA-II Clinical Trial

VANCOUVER and MINNEAPOLIS, Nov. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) ( NASDAQ , TSX : NVCN) today announced an update on the COSIRA-II Clinical Trial (“Trial”) status. COSIR...

NVCN:CC - Neovasc Announces Third Quarter Financial Results and Provides Corporate Update

VANCOUVER and MINNEAPOLIS, Nov. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the third quarter ended September 30, 2022. Recent Highlights ...

NVCN:CC - Neovasc Reducer Obtains U.S. Outpatient Reimbursement

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - November 8, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced that the Centers for Medicare and Medicaid Services ("CMS") has assigned the Neovasc Reducer™ ("Reduc...
Next 10